PPARG Epigenetic Deregulation and Its Role in Colorectal Tumorigenesis

被引:33
作者
Sabatino, Lina [1 ]
Fucci, Alessandra [1 ]
Pancione, Massimo [1 ]
Colantuoni, Vittorio [1 ]
机构
[1] Univ Sannio, Dept Biol Geol & Environm Sci, I-82100 Benevento, Italy
关键词
PROLIFERATOR-ACTIVATED-RECEPTOR; INTESTINAL POLYP FORMATION; GAMMA LIGAND TROGLITAZONE; ABERRANT CRYPT FOCI; DE-NOVO METHYLATION; HUMAN BREAST-CANCER; LONG NONCODING RNA; DNA METHYLATION; COLON-CANCER; CELL-GROWTH;
D O I
10.1155/2012/687492
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Peroxisome proliferator-activated receptor gamma (PPAR gamma) plays critical roles in lipid storage, glucose metabolism, energy homeostasis, adipocyte differentiation, inflammation, and cancer. Its function in colon carcinogenesis has largely been debated; accumulating evidence, however, supports a role as tumor suppressor through modulation of crucial pathways in cell differentiation, apoptosis, and metastatic dissemination. Epigenetics adds a further layer of complexity to gene regulation in several biological processes. In cancer, the relationship with epigenetic modifications has provided important insights into the underlying molecular mechanisms. These studies have highlighted how epigenetic modifications influence PPARG gene expression in colorectal tumorigenesis. In this paper, we take a comprehensive look at the current understanding of the relationship between PPAR gamma and cancer development. The role that epigenetic mechanisms play is also addressed disclosing novel crosstalks between PPARG signaling and the epigenetic machinery and suggesting how this dysregulation may contribute to colon cancer development.
引用
收藏
页数:12
相关论文
共 143 条
  • [71] Fine-tuning the lipogenic/lipolytic balance to optimize the metabolic requirements of cancer cell growth: Molecular mechanisms and therapeutic perspectives
    Menendez, Javier A.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2010, 1801 (03): : 381 - 391
  • [72] Involvement of PPAR nuclear receptors in tissue injury and wound repair
    Michalik, L
    Wahli, W
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (03) : 598 - 606
  • [73] Peroxisome-proliferator-activated receptors and cancers: Complex stories
    Michalik, L
    Desvergne, B
    Wahli, W
    [J]. NATURE REVIEWS CANCER, 2004, 4 (01) : 61 - 70
  • [74] International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors
    Michalik, Liliane
    Auwerx, Johan
    Berger, Joel P.
    Chatterjee, V. Krishna
    Glass, Christopher K.
    Gonzalez, Frank J.
    Grimaldi, Paul A.
    Kadowaki, Takashi
    Lazar, Mitchell A.
    O'Rahilly, Stephen
    Palmer, Colin N. A.
    Plutzky, Jorge
    Reddy, Janardan K.
    Spiegelman, Bruce M.
    Staels, Bart
    Wahli, Walter
    [J]. PHARMACOLOGICAL REVIEWS, 2006, 58 (04) : 726 - 741
  • [75] Motomura W, 2000, CANCER RES, V60, P5558
  • [76] Terminal differentiation of human breast cancer through PPARγ
    Mueller, E
    Sarraf, P
    Tontonoz, P
    Evans, RM
    Martin, KJ
    Zhang, M
    Fletcher, C
    Singer, S
    Spiegelman, BM
    [J]. MOLECULAR CELL, 1998, 1 (03) : 465 - 470
  • [77] Identification characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPAR gamma 2 versus PPAR gamma 1 and activation with retinoid X receptor agonists and antagonists
    Mukherjee, R
    Jow, L
    Croston, GE
    Paterniti, JR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (12) : 8071 - 8076
  • [78] PPAR trilogy from metabolism to cancer
    Nahlé, Z
    [J]. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2004, 7 (04) : 397 - 402
  • [79] Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex
    Nan, XS
    Ng, HH
    Johnson, CA
    Laherty, CD
    Turner, BM
    Eisenman, RN
    Bird, A
    [J]. NATURE, 1998, 393 (6683) : 386 - 389
  • [80] Dose-dependent suppression of hyperlipidemia and intestinal polyp formation in Min mice by pioglitazone, a PPARγ ligand
    Niho, N
    Takahashi, M
    Shoji, Y
    Takeuchi, Y
    Matsubara, S
    Sugimura, T
    Wakabayashi, K
    [J]. CANCER SCIENCE, 2003, 94 (11) : 960 - 964